Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatment naïve and…

Overview of attention for article published in Therapeutics and Clinical Risk Management, June 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

policy: 2 policy sources

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 72 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

Anakinra for treating Still’s disease : Appraisal consultation committee papers

Cited by National Institute for Health and Care Excellence on 16 Dec 2020

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV: interim guidelines: supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection

Cited by World Health Organization on 27 Dec 2018

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.